Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4131 USD | +3.28% | +2.20% | -10.22% |
03-20 | UBS Adjusts Singular Genomics Systems Price Target to $0.50 From $0.40, Maintains Neutral Rating | MT |
03-18 | Transcript : Singular Genomics Systems, Inc., Q4 2023 Earnings Call, Mar 18, 2024 |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Bearish | Neutral | Neutral |
Resistance | 0.4278 | 0.6100 | 1.080 |
Spread/Res. | -3.44% | -32.28% | -61.75% |
Spread/Supp. | +9.58% | +17.99% | +24.05% |
Support | 0.3770 | 0.3501 | 0.3330 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- OMIC Stock
- Charts Singular Genomics Systems, Inc.